Reply to Thomas Gevaert, Markus Eckstein, Rodolfo Montironi, and Antonio Lopez-Beltran's Letter to the Editor re: Maud Rijnders, Astrid A.M. van der Veldt, Tahlita C.M. Zuiverloon, et al. PD-L1 Antibody Comparison in Urothelial Carcinoma. Eur Urol 2019;75:538-40

Affiliations

¹ Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.
² Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands; Department of Radiology & Nuclear Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
³ Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands. Electronic address: r.dewit@erasmusmc.nl.
⁴ Department of Pathology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.

Comment

Maud Rijnders et al. Eur Urol. 2019 Jun.

. 2019 Jun;75(6):e160-e161.

doi: 10.1016/j.eururo.2019.01.039. Epub 2019 Feb 2.

¹ Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.
² Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands; Department of Radiology & Nuclear Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
³ Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands. Electronic address: r.dewit@erasmusmc.nl.
⁴ Department of Pathology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.

No abstract available

Comment on

PD-L1 Antibody Comparison in Urothelial Carcinoma.
Rijnders M, van der Veldt AAM, Zuiverloon TCM, Grünberg K, Thunnissen E, de Wit R, van Leenders GJLH. Rijnders M, et al. Eur Urol. 2019 Mar;75(3):538-540. doi: 10.1016/j.eururo.2018.11.002. Epub 2018 Nov 27. Eur Urol. 2019. PMID: 30497882 No abstract available.
Re: Maud Rijnders, Astrid A.M. van der Veldt, Tahlita C.M. Zuiverloon, et al. PD-L1 Antibody Comparison in Urothelial Carcinoma. Eur Urol 2019;75:538-40.
Gevaert T, Eckstein M, Montironi R, Lopez-Beltran A. Gevaert T, et al. Eur Urol. 2019 Jun;75(6):e162-e163. doi: 10.1016/j.eururo.2019.01.038. Epub 2019 Feb 1. Eur Urol. 2019. PMID: 30712970 No abstract available.